SCHEMBL613220

SCHEMBL613220

CCCC#Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
THPO P40225 1/20 0.54
NPSR1 Q6W5P4 1/20 0.53
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
HTR2A P28223 1/20 0.50
APP P05067 1/20 0.50
HRH3 Q9Y5N1 2/20 0.48
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9784179 1.00 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL614578 0.86 CYP1A2 (0.50) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL10437206 0.86 NPC1 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL10768214 0.85 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL5314931 0.85 FFAR1 (0.55) CYP1A2CYP3A4CYP2C9CYP2C19THPO
Hydrochloric Acid SCHEMBL31144511 0.85 BLM (0.52) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL9094995 0.85 NPSR1 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL5089564 0.83 NPSR1 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL4071200 0.83 FFAR1 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL4073903 0.83 FFAR1 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118515716-A NNN-pyridine-quinoline cobalt complex, preparation method and catalytic alkyne hydrosilylation reaction 石河子大学 2024-08-20 CN claimed
CN-111592607-B Application of covalent organic framework material of supported rhodium catalyst in alkyne polymerization 北京理工大学 2023-06-20 CN claimed
CN-111822052-B Preparation method of catalyst obtained by modifying palladium, catalyst and application 厦门大学 2021-12-03 CN claimed
CN-111774096-B Catalyst modified by thiol ligand and preparation method and application thereof 厦门大学 2021-12-03 CN claimed
CN-111822052-A Preparation method of catalyst obtained by modifying palladium, catalyst and application 厦门大学 2020-10-27 CN claimed
CN-111774096-A Catalyst modified by thiol ligand and preparation method and application thereof 厦门大学 2020-10-16 CN claimed
CN-111592607-A Application of covalent organic framework material loaded with rhodium catalyst in alkyne polymerization 北京理工大学 2020-08-28 CN claimed
CN-105688999-B Acetylacetone copper(II)The method that 1,2,3- triazole compounds are catalyzed and synthesized in supercritical CO 2 medium 河南师范大学 2018-07-13 CN claimed
CN-105085157-B A kind of synthetic method of 1,3- diacetylene class compound 河南师范大学 2018-06-19 CN claimed
US-9920160-B2 Method for synthesis of polymer containing multiple epoxy groups ZHEJIANG UNIVERSITY (CN) 2018-03-20 US claimed
US-6583315-B2 Reacting yellow elemental phosphorus with an alkyl halide under alkaline conditions; acidifying, esterifying, isolating and hydrolyzing to obtain purified alkylphosphonous acid; reacting with acetylene CLARIANT GMBH (DE) 2003-06-24 US claimed
US-20030073865-A1 PROCESS FOR PREPARING ETHANEBIS(ALKYLPHOSPHINIC) ACIDS CLARIANT GMBH 2003-04-17 US claimed
US-20030006699-A1 Light emitting device and method of manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2003-01-09 US claimed
US-6479191-B1 COMPRISING A NON-AQUEOUS SOLVENT, AN ELECTROLYTE SALT DISSOLVED THEREIN AND AT LEAST ONE ALKYNE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2002-11-12 US claimed
US-20020082447-A1 Process for preparing ethylenediphosphonic acids CLARIANT GMBH 2002-06-27 US claimed
CN-1322027-A Electrolyte for secondary lithium cell and secondary lithium cell therewith UBE INDUSTRIES (JP) 2001-11-14 CN claimed
EP-0827495-A4 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORP (US) 1998-11-04 EP claimed
EP-0827495-A1 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1998-03-11 EP claimed
WO-1997003945-A1 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1997-02-06 WO claimed
EP-0411332-B1 Antiviral peptides having a 2-oxoalkyl amino acid side chain BIO MEGA BOEHRINGER INGELHEIM (CA) 1995-12-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073865-A1 PROCESS FOR PREPARING ETHANEBIS(ALKYLPHOSPHINIC) ACIDS HAO2, ARSA, APEH CYP1A2 958/4885CYP3A4 797/4885CYP2C9 458/4885
US-20020082447-A1 Process for preparing ethylenediphosphonic acids ENPP1, ALK, INPPL1 CYP1A2 1166/4885CYP3A4 1361/4885CYP2C9 480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.